COVINA, CA -- (MARKET WIRE) -- February 27, 2007 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announced today that the Company’s non-embryonic stem cell technology is being prepared for clinical trials. The Company has researched and is preparing to submit an application through an Independent Institutional Review Board to pursue a clinical trial for the utilization of fat-based stem cells in the field of plastic and reconstructive surgery. Institutional Review Board (IRB) and other approvals must be received at the initial study sites before opening for enrollment.
